13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 72 holding rows worth $1,518,444,000.
- Accession
- 0001583977-23-000002
- Filer
- CIK 1583977
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 72 entries on the cover page, a total value of $1,518,444,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,518,444,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 1,655,000 | $177,615,000 | thousands, detected and multiplied | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 6,892,101 | $147,422,000 | thousands, detected and multiplied | |
| BIOMEA FUSION INC | 09077A106 | CMN | 3,570,872 | $110,733,000 | thousands, detected and multiplied | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,360,000 | $89,706,000 | thousands, detected and multiplied | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 8,500,000 | $75,820,000 | thousands, detected and multiplied | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 4,557,414 | $75,562,000 | thousands, detected and multiplied | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,600,000 | $49,296,000 | thousands, detected and multiplied | |
| 89BIO INC | 282559103 | COM | 2,800,000 | $42,644,000 | thousands, detected and multiplied | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,936,133 | $42,401,000 | thousands, detected and multiplied | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,612,115 | $40,096,000 | thousands, detected and multiplied | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,700,000 | $39,100,000 | thousands, detected and multiplied | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,444,000 | $38,410,000 | thousands, detected and multiplied | |
| ERASCA INC COM | 29479A108 | Stock | 10,813,246 | $32,548,000 | thousands, detected and multiplied | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,561,696 | $31,499,000 | thousands, detected and multiplied | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 5,150,000 | $29,716,000 | thousands, detected and multiplied | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,978,660 | $26,033,000 | thousands, detected and multiplied | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 2,386,181 | $23,170,000 | thousands, detected and multiplied | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 2,893,717 | $22,542,000 | thousands, detected and multiplied | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 850,000 | $21,624,000 | thousands, detected and multiplied | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 2,536,617 | $21,587,000 | thousands, detected and multiplied | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,946,887 | $19,656,000 | thousands, detected and multiplied | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 300,000 | $18,504,000 | thousands, detected and multiplied | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,421,422 | $17,867,000 | thousands, detected and multiplied | |
| AXONICS INC | 05465P101 | COM | 322,240 | $17,581,000 | thousands, detected and multiplied | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,050,000 | $17,483,000 | thousands, detected and multiplied | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 4,116,949 | $16,262,000 | thousands, detected and multiplied | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 110,000 | $15,161,000 | thousands, detected and multiplied | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,821,739 | $15,066,000 | thousands, detected and multiplied | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 868,550 | $14,878,000 | thousands, detected and multiplied | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 80,000 | $14,531,000 | thousands, detected and multiplied | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 576,373 | $13,712,000 | thousands, detected and multiplied | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,000,000 | $13,300,000 | thousands, detected and multiplied | |
| MORPHIC HLDG INC | 61775R105 | COM | 325,000 | $12,233,000 | thousands, detected and multiplied | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 650,000 | $11,928,000 | thousands, detected and multiplied | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,271,429 | $11,087,000 | thousands, detected and multiplied | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,082,000 | $10,695,000 | thousands, detected and multiplied | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 296,000 | $10,416,000 | thousands, detected and multiplied | |
| VAXCYTE INC COM | 92243G108 | Stock | 275,000 | $10,307,000 | thousands, detected and multiplied | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 2,353,141 | $9,436,000 | thousands, detected and multiplied | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,087,807 | $9,061,000 | thousands, detected and multiplied | |
| PRIME MEDICINE INC | 74168J101 | COM | 734,350 | $9,033,000 | thousands, detected and multiplied | |
| LIANBIO ADR | 53000N108 | COM | 4,250,000 | $8,330,000 | thousands, detected and multiplied | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 700,000 | $7,553,000 | thousands, detected and multiplied | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 816,460 | $6,577,000 | thousands, detected and multiplied | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 616,786 | $6,038,000 | thousands, detected and multiplied | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 1,547,181 | $5,183,000 | thousands, detected and multiplied | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 350,000 | $5,047,000 | thousands, detected and multiplied | |
| ANNEXON INC | 03589W102 | COM | 1,250,000 | $4,813,000 | thousands, detected and multiplied | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 350,000 | $4,806,000 | thousands, detected and multiplied | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 593,043 | $4,738,000 | thousands, detected and multiplied | |
| GREENLIGHT BIOSCIENCES HOLDING | 39536G105 | Common Stock | 9,188,659 | $3,973,000 | thousands, detected and multiplied | |
| ICOSAVAX INC | 45114M109 | COM | 643,825 | $3,734,000 | thousands, detected and multiplied | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 1,952,032 | $3,709,000 | thousands, detected and multiplied | |
| BIOATLA INC | 09077B104 | COM | 1,181,115 | $3,165,000 | thousands, detected and multiplied | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,081,490 | $3,082,000 | thousands, detected and multiplied | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 1,000,000 | $3,080,000 | thousands, detected and multiplied | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 1,217,882 | $2,874,000 | thousands, detected and multiplied | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 612,079 | $2,767,000 | thousands, detected and multiplied | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 561,600 | $2,162,000 | thousands, detected and multiplied | |
| GALECTO INC | 36322Q107 | COM | 1,020,238 | $2,030,000 | thousands, detected and multiplied | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 900,649 | $1,693,000 | thousands, detected and multiplied | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 1,628,980 | $1,417,000 | thousands, detected and multiplied | |
| BIOHAVEN LTD | G1110E107 | COM | 81,963 | $1,120,000 | thousands, detected and multiplied | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 272,537 | $1,093,000 | thousands, detected and multiplied | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 392,167 | $722,000 | thousands, detected and multiplied | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 225,065 | $662,000 | thousands, detected and multiplied | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 1,481,511 | $504,000 | thousands, detected and multiplied | |
| GRAPHITE BIO INC | 38870X104 | COM | 199,547 | $489,000 | thousands, detected and multiplied | |
| CHEMOMAB THERAPEUTICS LTD | 16385C104 | SPONSORED ADS | 288,169 | $458,000 | thousands, detected and multiplied | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 540,600 | $402,000 | thousands, detected and multiplied | |
| ATRECA INC | 04965G109 | COM | 319,057 | $364,000 | thousands, detected and multiplied | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 25,664 | $138,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-23-000002 | this filing | 2023-05-15 | acceptance time not in the bulk data set |